[1]
Sangam, K. et al. 2017. EVALUATION OF PHARMACOECONOMIC DIRECT COST IN DIABETES PATIENTS. Asian Journal of Pharmaceutical and Clinical Research. 10, 4 (Apr. 2017), 38–40. DOI:https://doi.org/10.22159/ajpcr.2017.v10i4.8510.